Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 179 (4), 880-894.e10

Attacking Latent HIV With convertibleCAR-T Cells, a Highly Adaptable Killing Platform

Affiliations

Attacking Latent HIV With convertibleCAR-T Cells, a Highly Adaptable Killing Platform

Eytan Herzig et al. Cell.

Abstract

Current approaches to reducing the latent HIV reservoir entail first reactivating virus-containing cells to become visible to the immune system. A critical second step is killing these cells to reduce reservoir size. Endogenous cytotoxic T-lymphocytes (CTLs) may not be adequate because of cellular exhaustion and the evolution of CTL-resistant viruses. We have designed a universal CAR-T cell platform based on CTLs engineered to bind a variety of broadly neutralizing anti-HIV antibodies. We show that this platform, convertibleCAR-T cells, effectively kills HIV-infected, but not uninfected, CD4 T cells from blood, tonsil, or spleen and only when armed with anti-HIV antibodies. convertibleCAR-T cells also kill within 48 h more than half of the inducible reservoir found in blood of HIV-infected individuals on antiretroviral therapy. The modularity of convertibleCAR-T cell system, which allows multiplexing with several anti-HIV antibodies yielding greater breadth and control, makes it a promising tool for attacking the latent HIV reservoir.

Keywords: CAR-T; HIV latency; MicAbody; T cell therapy; bNAb; broadly neutralizing HIV antibodies; convertibleCAR-T; reduce-and-control; reservoir; shock-and-kill.

Conflict of interest statement

Declaration of Interests

None of the Gladstone/UCSF scientists have a commercial relationship with Xyphos Biosciences, Inc. KCK is an employee of Xyphos Biosciences, SRW is an employee and shareholder of Xyphos Biosciences, KL and NK are members of the Xyphos Biosciences scientific advisory board and DWM is a founder of Xyphos Biosciences, a shareholder, and member of its scientific advisory board. A patent application has been filed related to this work.

Similar articles

See all similar articles

Cited by 1 PubMed Central articles

LinkOut - more resources

Feedback